NEOGAP

Neogap Therapeutics is a privately held biopharmaceutical company focused on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund and is located on the Karolinska hospital grounds, Solna, Sweden... Neogap Therapeutics AB, a Swedish biotechnology company developing personalised cancer immunotherapy, has been granted a Chinese patent for its method of expanding tumour-specific T cells - a key component of the company's therapeutic approach. The grant strengthens Neogap's international IP position and supports its long-term strategy to protect and advance its proprietary technologies globally.

Also known as: Neogap Therapeutics, Neogap Therapeutics AB

Primary location: Solna Sweden